Get started
Author

Mahmoud Abu Amna

Observed names: Abu-Amna Mahmoud, M. A. Amna, M. Abu Amna, Mahmood Abu-Amna, Mahmud Abo-Amna, Mahmud Abu Amna
ORCID: 0000-0003-0571-9287
Observed ORCID: 0000-0003-0571-9287
OpenAlex ID: A5050827140
Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data
2017 · Elizabeth Dudnik, Mor Moskovitz, et al. · Lung Cancer · 103
Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients
2020 · Joshua Aviram, Gil Lewitus, et al. · Pharmaceuticals · 38
PDF
The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients
2022 · Joshua Aviram, Gil M. Lewitus, et al. · Frontiers in Pain Research · 26
PDF
Risk factors for non-Escherichia coli community-acquired bacteriuria
2012 · M. A. Amna, B. Chazan, et al. · Infection · 26
Neutrophil degranulation and severely impaired extracellular trap formation at the basis of susceptibility to infections of hemodialysis patients
2022 · Salti Talal, Khoury Mona, et al. · BMC Medicine · 25
PDF
The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern Oncology
2026 · Keren Rouvinov, Rashad Naamneh, et al. · Diagnostics · 18
PDF
Current and Emerging Therapeutic Strategies for Limited- and Extensive-Stage Small-Cell Lung Cancer
2025 · Walid Shalata, Rashad Naamneh, et al. · Medical Sciences · 13
PDF
Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review
2023 · Omar Badran, Mahmoud Abu Amna, et al. · Breast Cancer Targets and Therapy · 8
PDF
Efficacy of Tyrosine Kinase Inhibitors in ALK and EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases
2025 · Walid Shalata, Rashad Naamneh, et al. · Medical Sciences · 4
PDF
Too Much of a Good Thing: The Association of Elevated Vitamin B12 Levels and Outcomes in Patients With Cancer Treated With Immunotherapy
2023 · Ilit Turgeman, Anat Reiner Benaim, et al. · Journal of Immunotherapy · 4
181P: Anti-PD-1 antibodies in non-small cell lung cancer (NSCLC): The real-life setting experience
2016 · E. Dudnik, M. Moskovitz, et al. · Journal of Thoracic Oncology · 3
PDF
Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLC
2026 · Abed Agbarya, Kamel Mhameed, et al. · Medical Sciences · 1
PDF
Immune-related adverse events and clinical outcomes in advanced non-small cell lung cancer: does more toxicity predict better outcomes?
2026 · Abed Agbarya, Noa Shani Shrem, et al. · Frontiers in Immunology
PDF
Evaluating the Therapeutic Impact of Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer
2026 · Keren Rouvinov, Rashad Naamneh, et al. · Biomedicines
PDF
Integrating Advanced Neuro-Oncology Imaging into Guideline-Directed Multimodal Therapy for Brain Metastases: Evaluating Comparative Treatment Effectiveness
2025 · Keren Rouvinov, Rashad Naamneh, et al. · Technologies
PDF
MA09.03 Plasma Proteomics-based Models for Predicting Immunotherapy- and Chemotherapy-Related Toxicity in NSCLC Patients
2024 · J. Naidoo, D.R. Gandara, et al. · Journal of Thoracic Oncology
Breast cancer insights from Northern Israel: a comprehensive analysis of survival rates among Jewish and Arab women
2024 · Omar Badran, Salvatore Campisi-Pinto, et al. · Frontiers in Oncology
PDF
Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): A possible drug interaction?
2017 · M. Abu Amna, G. Bar-Sela · Annals of Oncology
Works count: 18
Citation count: 269
H-index: 8
I10-index: 7
Year
Topic
Type